NasdaqGS:CERTHealthcare Services
Certara (CERT): Evaluating Valuation Following Launch of Pinnacle 21 Enterprise Plus for Regulatory Data Compliance
If you’re watching Certara (CERT) for signs of a turnaround, the latest launch of Pinnacle 21 Enterprise Plus is worth your attention. This product promises a major shift in how clinical and statistical programmers handle complex regulatory data submissions, an area that has been bogged down by manual processes and inefficiencies for years. With the company touting up to a 50% reduction in time spent drafting mapping specifications, this move tackles a core pain point for its key customers...